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Background: Although general practitioners (GPs) and community pharmacists (CPs) are encouraged to collaborate,
a true collaborative relationship does not exist between them. Our objective was to identify and analyze factors
affecting GP-CP collaboration.
Methods: This was a descriptive-exploratory qualitative study carried out in two Spanish regions: Catalonia
(Barcelona) and Balearic Islands (Mallorca). Face-to-face semi-structured interviews were conducted with GPs and
CPs from Barcelona and Mallorca (January 2010-February 2011). Analysis was conducted using Colaizzi’s method.
Results: Thirty-seven interviews were conducted. The factors affecting the relationship were different depending on
timing: 1) Before collaboration had started (prior to collaboration) and 2) Once the collaboration had been initiated
(during collaboration). Prior to collaboration, four key factors were found to affect it: the perception of usefulness;
the Primary Care Health Center (PCHC) manager’s interest; the professionals’ attitude; and geography and legislation.
These factors were affected by economic and organizational aspects (i.e. resources or PCHC management styles)
and by professionals’ opinions and beliefs (i.e. perception of the existence of a public-private conflict). During
collaboration, the achievement of objectives and the changes in the PCHC management were the key factors
influencing continued collaboration. The most relevant differences between regions were due to the existence of
privately-managed PCHCs in Barcelona that facilitated the implementation of collaboration. In comparison with the
group with experience in collaboration, some professionals without experience reported a skeptical attitude towards
it, reporting that it might not be necessary.
Conclusions: Factors related to economic issues, management and practitioners’ attitudes and perceptions might
be crucial for triggering collaboration. Interventions and strategies derived from these identified factors could be
applied to achieve multidisciplinary collaboration.
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General practitioners (GPs) and community pharmacists
(CPs) are encouraged to collaborate to improve patient care
[1,2] Pharmacists’ interventions within the healthcare team
improve patient outcomes in physical [3-5] and mental con-
ditions [6]. On the other hand, miscommunication between* Correspondence: mrubio@pssjd.org
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distribution, and reproduction in any mediumGPs and CPs is a cause of preventable hospital admissions
[7]. However, during the implementation of a trial evaluat-
ing a complex intervention [8] we realized that GPs and
CPs had difficulties communicating with each other. Des-
pite working in the same geographical area and sharing
patients, some doctors and pharmacists used the study re-
searcher to transmit information to the other professional
or to obtain additional information about the participants.
Surveys have been conducted exploring this issue,
pointing out that exchange characteristics (i.e. trust-
worthiness or role specification) are the factors mostntral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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quantitative work provides only a limited understanding of
what promotes collaboration. Qualitative studies may
untangle some of the deeper reasons preventing such col-
laboration [11]. Qualitative work has been conducted in
the UK, Australia and USA to explore factors affecting
GP-CP collaboration [12-15]. These qualitative works high-
lighted the fact that professionals from each discipline were
not personally acquainted, territoriality, and the pharma-
cist’s conflict of interest with regard to selling medications
as the barriers that most affected mutual trust and respect
between practitioners, thus impeding collaboration. Some
of these studies explored the factors affecting collaboration
in areas where multiple chain pharmacies and single inde-
pendent pharmacies coexisted, reporting higher distrust
and lack of interest among GPs towards collaboration with
chain pharmacists. However, the impact on collaboration
of publicly funded and privately managed PCHC in com-
parison with publicly funded and publicly managed PCHCs
has not been previously assessed. Nor did these studies ex-
plore the perception of the Primary Care Health Centers
(PCHC) managers or the impact on the GP-CP relation-
ship of external agents that participate in the process such
as the patient and the pharmacy assistant.
Differences between the health systems and the model
of community pharmacy require a country-specific study
in Spain. The Spanish national health system (NHS) is
publicly funded. The organization and provision of
health services depends on each of the 17 regional gov-
ernments through which Spain is governed [16]. This
generates differences in health policies between regionsTable 1 Summary of the main characteristics of the PCHC and
Primary care health centers
Owner Predominantly state-owned
Every PCHC contains several GP surgeries with few exc
in rural areas of Spain
Funding Publicly funded
Management Predominantly publicly run (the manager is one of the
the PCHC team that combines clinical activities with
management activities)
In some regions, privately managed PCHCs exist. This i
case with the "Entitades de Base Asociativa" (EBAs). EBA
limited companies comprised of health professionals t
establish a contractual relationship with the NHS to of
services in exchange for capitation financing, a theoret
per person independent of the real costs incurred.
Compensation Most GPs are employed by the public sector and rece
salaries.
Management by Objectives (MBO) has been introduce
improve quality of the service and reduce cost. For ins
GPs are paid a bonus if they prescribe a high percenta
of generic drugs and/or those of proven efficacy.[17,18] which could affect the organization of primary
care health centers and pharmacies as well as the way in
which collaboration is manifested between GPs and CPs.
Table 1 summarizes the main characteristics of Spanish
primary care, comparing the organization of the PCHCs
and the pharmacies.
The aims of this study were: 1) to identify and analyse
barriers and facilitators in collaboration between GPs
and CPs in Spain and 2) to explore whether differences
exist between GPs and CPs based on the geographical re-
gion where they work and previous experience of
collaboration.
Methods
A descriptive-exploratory qualitative study using face-to-
face, semi-structured interviews (January 2010-February
2011) was undertaken using a phenomenological approach.
The study population comprised GPs and CPs from 2
Spanish regions: Catalonia (Barcelona) and the Balearic
Islands (Mallorca). Commitment to primary care is
higher in Catalonia than in Balearic Islands and there is
a greater investment of resources in primary care with
respect to total health expenditure [18] Consequently, in
comparison with Balearic Islands, there is a higher dens-
ity of PCHCs, a lower ratio of patients per GP, a greater
number of services integrated within primary care (i.e.
dentistry) and better access to diagnostic procedures by
GPs in Catalonia. A further important difference be-
tween the regions is the coexistence of the private and
public model in Catalonia, which is reflected in the
presence of "Entidades de Base Asociativa” (EBAs) (seecommunity pharmacies in Spain
Community pharmacies
Privately owned (the pharmacy owner must be a
licensed pharmacist and each pharmacy may own only
one pharmacy)
eptions
Offers both publicly funded services (i.e. drugs that are
financed by the state) and privately funded services
(i.e. over the counter drugs)
A large part of the profit derives from selling financed
drugs.






ive fixed CPs are owners of the community pharmacy or
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regions management by objectives (MBO) is used. The
MBO system gives GP incentives (usually financial) if
they fulfill the objectives set by the health system (i.e.
prescription of drugs of proven efficacy). Electronic pre-
scribing links the GP’s prescriptions with the community
pharmacists and acts as a communication channel be-
tween the two professionals. The implementation of
electronic prescribing in the Balearic Islands began
in 2006, long before its introduction in Catalonia. By
the time we conducted the study interviews, elec-
tronic prescription had long been established in the
Balearic Islands while in Catalonia only GPs and CPs
from some areas were using it, primarily in rural
areas and small cities. In Barcelona, it was in the im-
plementation stage.
We also considered whether recruited practitioners
had previous experience of collaboration (defined as hav-
ing had regular face-to-face contact with the other group
of professionals). We theorized that practitioners from
different regions and those with previous experience
compared with those with none would have different
opinions towards collaboration thus maximizing the pos-
sibility of finding disconfirming cases (theoretical sam-
pling [11]).
The PCHC manager in Spain is usually a GP from the
team of physicians who combines clinical work with the
management of the PCHC. While in charge, the manager
officially represents the PCHC and he/she administers
the human and financial resources allocated to the health
center. Consequently, the PCHC manager is responsible
for distribution of the resources necessary for collabor-
ation with the CP. Some of the GPs interviewed had ex-
perience as managers of the PCHC.
We contacted key informants from the fields of pri-
mary care (PC) and community pharmacy in Barcelona
and Mallorca [the College of CPs, the Research Network
on Preventative Activities and Health Promotion
(RedIAPP) in PC and the School of Pharmacy-University
of Barcelona] to identify those professionals who
matched our sampling criteria. It was explained to the
key informants that we were seeking professionals with
experience of collaboration so that we would be referred
to professionals whom we knew in advance would take
part. Thereafter, practitioners were contacted by tele-
phone and invited to participate. At this time we estab-
lished a time for the interview but did not explain the
study objective in detail. We did, however, ask them
some brief questions, including whether they collabo-
rated with any other health professionals. Once inter-
viewed, participants were asked if they knew other
practitioners who matched our criteria (snowball sam-
pling [19]). One general practitioner declined to
participate.Participants were recruited until each theorized cat-
egory (professional group, previous experience and re-
gion) independently achieved saturation of thematic
findings.
Interviews were conducted in a place of convenience for
the participant by AMJ (GPs from Barcelona), MRV (CPs
from Barcelona), MG (GPs from Mallorca) and MR (CPs
from Mallorca). The interview guide was developed by a
team of researchers and clinicians including AMJ, AF and
MRV taking into account their experience in the field as
well as the results of the only paper that had been pub-
lished at the time the study was designed [13]. The inter-
view guide was piloted with one GP and one CP. The
interview guide is summarized in Table 2. Interviews were
audiorecorded, fully transcribed and anonymized.
In parallel with interviews, analysis assisted by Atlas-ti
software was conducted. The information obtained was
triangulated by the participation of three investigators [a
GP (AMJ), a pharmacist (MRV) and a psychologist with
experience in using qualitative research (AF)] who inde-
pendently analyzed the interviews [11]. In the Mallorca
interviews, a fourth analyst participated [a nurse and
sociologist (MG) from Mallorca].
Analysis was conducted using Colaizzi’s method for
analysis [20]. The following is a complete description of
the procedure. The process of generation of categories
was largely inductive. Researchers became familiar with
the interviews by listening, reading and re-reading them.
Themes were identified and coded independently by
each of the researchers involved in the analyses.
Researchers then came together to compare and discuss
differences in the analyses. Themes were then re-coded
and classified, identifying common patterns and conver-
gences and divergences in data through a process of con-
stant comparison. With the assistance of a fifth
researcher, a pharmacist with experience in undertaking
qualitative research and collaboration between pharma-
cists and GPs (CMH), findings from the analysis were
integrated to formulate a theoretical model for the
phenomenon under investigation. Finally, respondent
validation was conducted, comparing our interpretation
of the phenomenon with those who had participated.
Participants were sent a summary of the findings and
invited to a meeting where findings were presented and
discussed. Fourteen out of thirty-seven professionals par-
ticipated in this validation. Changes suggested by partici-
pants were incorporated into the final description of the
phenomenon.
In order to guarantee the validity of this research
[11,21] the study was externally audited from the begin-
ning to its conclusion by a group of researchers from
the "Qualitative Health Research Group" (led by Dr
Vázquez ML) of the "Consorci de Salut i Social de Cata-
lunya". Interviewers and main analysts kept a personal
Table 2 Topic guide for the interview
Topic guide Suggested questions to help the interviewer
Relationship nowadays How is your relationship with the CP/GP?
- If there is no relationship: Why do you think that there is no relationship?
- If the relationship is good/bad/regular: What do you think that makes the relationship good/bad/regular?
Utility of the collaboration Do you think that it would be useful to potentiate the teamwork between the GP and CP? Why?
What advantages do you see in working in collaboration with the CP/GP?
And what disadvantages do you see in collaborating with the CP/GP?
Opinion about the other
group of professionals
What do you think about the CP/GP?
How do you think that CP/GPs see GP/CPs?
Barriers for communication If you tried to get in contact with the CP/GP at any time, what difficulties did you have?
You told me that when trying to get in contact with the CP/GP you had problems
because. . . can you think of any others?
Barriers for collaboration What do you think makes collaborative work difficult?
Facilitators for communication What steps do you think could be taken to improve communication with CPs/GPs?
Facilitators for collaboration How do you think collaborative work could be promoted or strengthened?
Impact from the National Health
System
Is there any aspect in the organization of the health system that you think is affecting the
relationship between GPs and CPs? In what sense?
GP=General practitioner; CP = Community pharmacist.
Table 3 Characteristics of the participants
Characteristics of participants (n = 37) Barcelona Mallorca




Mean age (range), years 48.7 (35–60) 47.6 (37–60)
Mean clinical work experience
(range)*, years
21.8 (8–31) 19.6 (8–30)
Previous experience in GP-CP
collaboration, n
With previous experience 4 5
Without previous experience 5 4




Mean age (range), years 50.4 (30–64) 47.7 (29–56)
Mean clinical work experience
(range), years
23.7 (5–40) 17.2 (1–30)
Previous experience in GP-CP
collaboration, n
With previous experience 5 4
Without previous experience 5 5
* Three general practitioners from Barcelona and four from Mallorca also had
experience as Primary Care Health Center managers.
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during the research were recorded. All participants gave
informed consent and the study was approved by the
Foundation Sant Joan de Déu Clinical Research Ethics
Committee.
Results
A total of 37 interviews were conducted that lasted 5–99
minutes (mean: 23 minutes) (Table 3 shows the sample
characteristics). Nine GPs and nine CPs had had previ-
ous experience in collaboration with the other group of
professionals and 4 of the GPs belonged to an EBA.
In the group of participants with previous experience
the collaborative experiences differed from one another.
Some examples of activities were: interdisciplinary pro-
fessional training, detection and resolution of medication
related problems, carrying out tests or clinical analysis
(e.g., glycemia) at the pharmacy for patients who require
regular monitoring, rationalization of expenses, special
care for people with mobility problems, personalized
medication dosage system (weekly blister packs for
patients taking a variety of medications) and public
health education, and so on.
Factors affecting GP-CP collaboration
The factors affecting the relationship varied depending on
the timing in relation to the collaboration: 1) Before col-
laboration started (prior to collaboration) and 2) Once the
collaboration had been initiated (during collaboration).
Prior to collaboration, GPs and CPs worked on their
own. This first phase was a process of team-building that
allowed collaboration to begin. The factors identified
assigned to this first stage in the process of generationof the theoretical model were central in facilitating or
impeding the initiation of collaboration between the two
professions.
During collaboration, a successful relationship between
doctors and pharmacists has been established and the
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from this point on is to maintain and consolidate collab-
oration to ensure continuity.
Practitioners from the group which had experience of
collaboration provided data which was rich in the identifi-
cation of collaboration facilitators. GPs and CPs without
experience who had tried to collaborate without success
provided information about barriers which prevented or
limited collaboration. Finally, GPs and CPs without experi-
ence who had never engaged in collaboration reported bar-
riers related to attitudes and preconceived perceptions.
Prior to collaboration
Prior to the process 4 key factors were identified which
affected collaboration: A) perception of usefulness, B)
PCHC manager’s interest, C) attitude, and D) geography
and legislation. Figure 1 shows the conceptual model of
factors affecting the initiation of the collaborative rela-
tionship between GP and CP.
Perception of usefulness
A positive perception of usefulness was necessary in
order to start the collaboration. Conversely, the percep-
tion of usefulness was negative when GPs and CPs
believed that there were no advantages in collaborating
or that collaboration would cause problems. Only profes-
sionals without previous experience from Barcelona
thought that collaboration would be troublesome.
I think we shouldn’t tamper with it (the relationship
with the doctor) because I think that it’s correct . . . ifFigure 1 Factors affecting collaboration between general practitioner
Primary Care Health Center; EBA: type of privately managed PCHC; GPs: Genwe look for something more we will have problems.
[CP2: Community pharmacist without experience in
collaboration from Barcelona (CP WO BCN)].
However, participants stated that there were some fac-
tors that could influence a positive perception of useful-
ness. GPs and CPs with previous experience reported that
evidence supporting positive outcomes of collaborative
GP-CP relationships could make professionals change
their mind about collaboration. Similarly, professionals sta-
ted that sometimes the NHS introduced strategies that
affected both groups of professionals, e.g., the introduction
of electronic prescribing, which could force a collaboration
to start.
But thanks to electronic prescribing, given that just like
any implementation of a system in which we are forced
to work together . . . has forced this exchange, this
feedback with the medical team . . . we have
established a series of courses of action with the aim of
having more fluid communication to solve this
problem. [CP10: Community pharmacist with
experience in collaboration from Barcelona (CP W
BCN)]
PCHC manager interest
To collaborate it was necessary that the PCHC manager
was interested in promoting collaboration.
I think that a lot depends on the will of the manager of
the PCHC; whether the manager of the PCHC is ins and community pharmacists prior to collaboration. PCHC:
eral practitioners; CPs: Community pharmacists.
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against (cooperation). Now they have changed this and
she is already waiting for me. [CP1: CP WO BCN]
The interest of the PCHC manager was influenced by
his/her own perception of usefulness and by the initial cost
in terms of infrastructure and human resources required
to trigger the collaboration. EBA-type PCHCs in Barcelona
were a good example of this (see Table 1). GPs and CPs
suggested that collaboration was easier for two reasons:
because the PCHC manager would be interested in collab-
oration as a strategy to reduce costs and improve out-
comes for the center and because these PCHCs had
smaller teams which were easier to coordinate.
The advantage of centers like this (EBA) is that this
health center is a small center. . . . There is more
flexibility and greater speed when we want to get a
project going. [GP8: General Practitioner with
experience in collaboration from Barcelona (GP W
BCN)].
A barrier influencing the manager’s interest was the per-
ception that the NHS did not incentivize collaboration.
Attitude of the professionals
Attitude was strongly influenced by opinions held
about the other professional. A good opinion would
lead to respect and trust; key factors for collaboration.
A negative opinion might be due to the perception
that a “public-private” conflict existed. GPs and CPs
believed that, through MBO (see Table 1) doctors
were encouraged to prescribe cheaper drugs and less
of them while the pharmacist, through selling medica-
tions, had a greater interest in non-rational use of
medicines.
(Pharmacists must think) that we are forced by the
health policies that reward or punish some prescription
styles . . . There are many doctors that (say) “I’m not
giving (prescribing) this, do you know why? Because I’ll
get into trouble, because they’ll penalize me”. . . They
(CP) must think, “Here, it’s my money that’s at stake,
because I have a business and the doctor is a state
employee and nothing’s going to happen to him/her
and he/she doesn’t care.”. . . And they must compare
this difference of their feeling of responsibility, that they
have a business and they must pay a salary to their
assistants, that there are things to pay for. They have
an element of the entrepreneur that we don’t have.
[GP8: GP W BCN]
Overlapping responsibilities generated a negative opin-
ion of the other professional. GPs and CPs believed thatsometimes the other professional was performing tasks
that should not be done by him/her. This concern was
generated by the fact that the roles of professionals were
not well defined.
We have the experience of seeing a productive cough, a
dry cough, some mucosity. I think we can recommend
a medication . . . a doctor will tell you: “but well, we
are doctors and it is us who have to (prescribe)” and,
well, he/she is right, on the one hand they’re right, but
where is the line where we end and the doctor begins,
you know? [CP7: CP WO BCN]
GPs and CPs believed that patients generated conflict
by relaying biased information or directly criticizing pro-
fessionals.
(The patient) is a tell-tale (laughs). Sometimes they
also tell lies, you know? . . . They tell lies to both groups
(the doctors and the pharmacists). This is also true,
eh? They are blackmailers, they blackmail to get what
they want. [CP6: CP W BCN]
Pharmacy assistants created conflict by assuming roles
of the pharmacist. This affected quality of patient care
and the relationship with the doctor, who preferred to
communicate with the pharmacist.
For some years, anybody could start off being the
pharmacy guy (pharmacy assistant) . . . He then started
dispensing and ends up putting on a white coat and
finally he acts as a pharmacist . . . the boss, the
licensed pharmacist, he is almost always there but if
he/she is not there, and I need to talk about something
and I need his/her knowledge [GP8: GP W BCN]
However, the view about the other profession changed
when practitioners knew each other. Stigmatized views
and conflicts were resolved.
The main advantage when collaboration is established
is that it breaks a series of stereotypes that exist from
the doctor towards the pharmacist, that there is
intrusiveness, this or that. . . and the opposite, from the
pharmacist towards the doctors, that they are
arrogant, that they do this or that, all these things stop
when two professionals with similar knowledge, or even
a similar age, see each other, a lot of barriers are
broken. [CP16: Community pharmacists with
experience from Mallorca (CP W MLL)]
Another factor that may contribute to improving the
physician’s opinion of the pharmacist is the existence of
shared goals to improve service, preferably if they are
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was only possible if the pharmacists involved in the team
were highly trained and clinically competent.
Initiating collaboration involved extra work for these busy
professionals who received no additional remuneration for
it. GPs and CPs stated that their attitude would be even
worse if the NHS forced them to collaborate without releas-
ing them from other duties or offered economic incentives.
To attend to a patient, time is needed and this time is
also money. And trained people are needed. For
training, time and money are needed, you see?
Everything until now has been paid by the pharmacist
him/herself. . . . If fewer human resources are available,
then somewhere we will have to make cuts. [CP10: CP
W BCN]
Geography and legislation
Legislative and geographical factors had the potential to
increase the effort required to coordinate collaboration,
which in turn also affected the professionals’ attitudes. In
poorly defined geographic areas with no clear neighbor-
hood divisions, there were a large number of pharmacies
and/or some of them were far from the PCHC. By law,
patients can choose any pharmacy to fill their prescrip-
tion and can switch from one to another in successive
visits, making collaboration difficult. Therefore, profes-
sionals felt that working together was easier in small
areas or when pharmacists in the area worked together
and coordinated the delivery of services between them.
What happens is that I have the advantage that I am
in a basic unit where I have a single reference
pharmacy. So, of course, there is only one pharmacy
with which I have regular contact . . . which is a very
big advantage. [GP17: General practitioner with
experience from Mallorca (GP W MLL)]
According to GPs and CPs, another barrier is caused
because pharmacies are privately owned and pharmacists
are not seen as part of the health system structure.
I consider that the structure clearly leaves the
pharmacist outside the national health system. That’s
why the pharmacists don’t know which entity they are
part of. We are private centers with an agreement with
the administration. Yes, we are obliged to follow all the
administration guidelines . . . because we are
dispensing national health system prescriptions but
then we are not considered as being part of the health
system in any way. Not structurally, organizationally,
legally, nowhere. If one is not considered (as part of the
system) it is very difficult to be part of it. [CP16: CP
W MLL]In the current system, pharmacy income is mainly cen-
tered on the payment for dispensing medications.
Pharmaceutical care services which do not involve the
sale of medications are, therefore, not remunerated so
that doctors and pharmacists think that the system pro-
motes an economic conflict of interest that makes it dif-
ficult for the pharmacist to collaborate on clinical tasks.
What we want is what is right for the patient. And, of
course, earn our living with the medications . . . if only
they paid me differently. That is a problem. I mean, I
think that a problem that our relationship could have
(the doctor with the pharmacist) is the idea that the
doctor has that the pharmacist makes a profit from the
medication. And I think that, well, we are earning a
living, of course, and at the moment we earn a living
with medications. It’s a handicap we have. [CP4: CP
WO BCN]
Some doctors and pharmacists suggest that one pos-
sible solution is a change in the organization of the phar-
macy, integrating it into the health center itself.
One possible solution which is not totally unviable is to
create pharmacies inside the health center. So that
there is a pharmacy service like there is in the
hospitals. . . . De-privatize the pharmacies. [GP17: GP
W MLL]
During collaboration
Once collaboration had successfully started, the factors
that influenced the relationship changed. Two key fac-
tors were identified at this stage: A) achievement of
objectives and, B) change in the PCHC management.
Figure 2 shows the relationship between the factors
affecting GP-CP collaboration once collaboration had
begun.
Achievement of objectives
For the relationship to be maintained over time, both
professionals and the PCHC manager had to recognize
the benefit of this collaboration. There were a number of
factors that could help to fulfill the goals. According to
GPs and CPs, it seemed essential to have a coordinator
(s) or reference person(s), responsible for leading the col-
laboration and linking the two professional groups.
GPs and CPs felt that meetings needed to be held
regularly so that professionals could discuss shared
objectives. Meetings between GPs and CPs usually take
place in the PCHC at lunch time, when the pharmacies
are usually closed and the GPs change shifts so when
food was provided it encouraged attendance. While this
is not an ideal arrangement, the option of combining
lunch with meetings is the most practical solution in a
Figure 2 Factors affecting collaboration between general practitioners and community pharmacists once the collaboration has been
started. PCHC: Primary Care Health Center; CPs: Community pharmacists.
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many business premises, including pharmacies, close be-
tween 2-5 pm. It was important to share a clinical chart
so that both professionals could have access to complete
patient information. Standardized working methods as
well as standardized communication channels facilitated
collaboration. For non-urgent consultations, a referral
form assisted in information transmission.
One of the things that we had is that we phoned the
health center to have direct access to the doctor’s
surgery. We had the switchboard number,. . . each
doctor had a switchboard number and we dialled it. I
mean we went in directly. This meant that any
problem we had could be solved straight away. [CP6:
CP W BCN]
However, a positive attitude might change as a conse-
quence of the increased burden or lack of financing that
made collaboration impossible.
As we already have a lot of work, it couldn’t work and
it was cancelled. Because we all have enough work . . .
I don’t think there was any other reason, there was no
misunderstanding or anything else. It was just this, the
pressure they were under and ours too. [GP4: GP W
BCN]
In addition to workload, wasting time with personal
complaints in meetings could make GPs and CPs unwill-
ing to collaborate. Pharmacists needed to work with each
other and could be demotivated if they were unable to co-
operate with their colleagues. Finally, if GPs and CPs were
unable to agree on new objectives, collaboration would
end.
Sometimes we (GPs and CPs) have meetings in the
health center and the differences (between GPs’ andCPs’ interests) are so divergent that we don’t have
points in common. I mean, they (CPs) have their
interests, that if their stock, that if I don’t know what
. . . When we are having these meetings and you say:
“but if we (GPs) really don’t mind that the stock of
generics is this brand or another”. . . Sometimes they
speak about things that we don’t understand [GP13:
General practitioner without experience from
Mallorca (GP WO MLL)]
Change in PCHC management
If the new management team was not in favor of collabor-
ation, practitioners would no longer have time or support
to conduct meetings, collaborative work, etc.
The most important handicap appeared when they
(EBA’s managers) left. . . No other company was
contracted; they (the people of the NHS) decided to
manage the center by themselves. They designated a
new manager and, at the beginning, we explained to
her everything we had been doing and everything
looked fine to her “very good, very good, very good” but
we had neither meetings, nor health controls, nor. . . I
mean, everything diminished. [CP7: CP W BCN]
Discussion
Summary of main findings
This study highlights two stages associated with collabor-
ation: prior to and during collaboration. Key factors prior
to collaboration were perception of usefulness, PCHC man-
ager interest, attitude, and geography and legislation. At
this stage there was a process of team building that corre-
sponded to the first stages of the model of development of
Collaborative Working Relationship (CWR) [22] (Profes-
sional Awareness; Professional recognition; Exploration
and Trial). During collaboration, which corresponded to
the last stages (Professional expansion; Commitment to the
CWR), achievement of common objectives and PCHC
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perpetuating collaboration.
The most important difference between regions in
terms of collaboration was due to the presence of EBAs,
which only exist in Barcelona. Practitioners from this
type of privately managed center were more motivated
to initiate collaboration with the community pharmacies
and, once initiated, the relationship seemed to be easily
maintained over time.
Negative perception of usefulness was only reported by
GPs and CPs without experience in collaboration from
Barcelona. The fact that this particular view was only
reported by professionals without previous experience in
collaboration could be a consequence of previous bad
experiences when having contact with the other profes-
sional. Although we consider that it could be the other
way around and, in fact, it is the negative perception, or
prejudice against collaboration, that prevents it. Regional
differences cannot be explained with the information we
have at present. It is possible that the search for negative
cases (i.e. disconfirming cases) was more intensive in
Barcelona than in Mallorca although it is also possible
that the variance really is due to regional differences.
This issue will require further exploration.
GP and CP speech were similar and they agreed on the
majority of factors affecting collaboration. Although there
are differences in the factors which affect each type of pro-
fessional (i.e., the pharmacist’s conflict of interest is related
to an incentive to sell the greatest number of products while
that of the doctor is connected with offering a service in
which cutting costs results in salary bonuses) both profes-
sionals express them, being aware that this is the view
others have of them which, in turn, affects collaboration.Strengths and limitations
To the best of our knowledge, this is the first qualitative
study conducted by a multidisciplinary team and the first
conducted in Spain. Moreover, this is the first study that
compares samples from two regions with different geo-
graphical characteristics and health policies. Taking into
account distinct contexts improves the relevance of this
study. A series of quality control measures were used to
guarantee the trustworthiness of the conclusions.
Nevertheless, those who participated in the study were
more likely to be interested in this topic. However, we
recruited professionals without experience in collaboration
and who held negative views regarding collaboration.
Interviews were conducted by a number of investigators,
perhaps resulting in biased information, but an interview
guide was used and recorded interviews were audited.
However, CPs were interviewed by a pharmacist, and GPs
were interviewed by a GP or a nurse, encouraging openness
and honesty.Comparison with existing literature
Results from this study are consistent with previous re-
search [12-15]. The importance of mutual knowledge,
role definition, CPs’ conflict of interest and the territori-
ality of the GP concurs with previously reported results
[12-15] although in our study a problem with territorial-
ity was also reported by pharmacists who felt that GPs
were assuming pharmacist roles. Since some GPs in
Spain are incentivized through MBO, a stereotypical
view of the GP being too worried about meeting targets
and being rewarded by the health system was also
demonstrated in our study.
Both professions had to perceive collaboration as eco-
nomically profitable. However, as highlighted by our
study, the PCHC manager also had to be motivated to
promote this collaboration. In privately managed
PCHCs, practitioners stated that collaborative care had
led to a reduction in expenses, which could have been a
motivation for managers to collaborate. This could be an
important factor to consider when implementing collab-
orative relationship in areas or countries where PCHCs
are privately managed.
Pharmacists in Spain only receive public funding for
providing prescription medicines. Consequently, barriers
related to lack of incentives from the NHS to initiate
and maintain collaborative work were highlighted. Previ-
ous studies have reported pharmacists’ concerns about
potential increases in workload and adequacy of remu-
neration when new services are introduced [23] seemed
to be a crucial factor in building multidisciplinary teams
[12,14,15]. When professionals meet, preconceptions
about the others can be overcome and shared aims,
strategies and tools to enhance communication and lead
to an improvement in services can be discussed. To
maintain collaboration, it is preferable to share clinical
objectives [14]. If only administrative issues are
addressed, physicians are not interested and pharmacists
feel frustrated. Working on clinical issues implies shar-
ing patient clinical information [14]. Ethical and security
considerations need to be taken into account when col-
laborating and the need for patient consent must be
considered [22].
Conclusions
A better understanding of the GP-CP relationship
enables us to develop strategies and interventions to
promote collaboration. The most relevant strategies to
implement are the encouragement of positive attitudes
and the perception of usefulness on the part of the
health administrators and professionals to take advan-
tage of the new changes or strategies imposed by the
health system as an opportunity to initiate collabor-
ation (common objective); to promote face-to-face rela-
tionship development to overcome prejudices and enable
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dinators responsible for coordinating teamwork; and to
establish standardized agreed communication. Future re-
search needs to be conducted to evaluate the effectiveness
of these strategies.
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